Related references
Note: Only part of the references are listed.Influence of molecular size on tissue distribution of antibody fragments
Zhe Li et al.
MABS (2016)
CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications
Anke Steinmetz et al.
MABS (2016)
Bispecific antibodies
Roland E. Kontermann et al.
DRUG DISCOVERY TODAY (2015)
A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism
Zhi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Alternative molecular formats and therapeutic applications for bispecific antibodies
Christoph Spiess et al.
MOLECULAR IMMUNOLOGY (2015)
The insulin/IGF system in colorectal cancer development and resistance to therapy
Paolo Giovanni Vigneri et al.
FRONTIERS IN ONCOLOGY (2015)
Four-in-One Antibodies Have Superior Cancer Inhibitory Activity against EGFR, HER2, HER3, and VEGF through Disruption of HER/MET Crosstalk
Shi Hu et al.
CANCER RESEARCH (2015)
New Horizons in Therapeutic Antibody Discovery: Opportunities and Challenges versus Small-Molecule Therapeutics
Alison J. Smith
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Competing aggregation pathways for monoclonal antibodies
Haixia Wu et al.
FEBS LETTERS (2014)
A Bispecific HER2-Targeting FynomAb with Superior Antitumor Activity and Novel Mode of Action
Simon Brack et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Steven M. Lewis et al.
NATURE BIOTECHNOLOGY (2014)
Systematic Characterization and Comparative Analysis of the Rabbit Immunoglobulin Repertoire
Jason J. Lavinder et al.
PLOS ONE (2014)
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Monoclonal antibody therapeutics with up to five specificities Functional enhancement through fusion of target-specific peptides
David W. LaFleur et al.
MABS (2013)
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2
Christian Jost et al.
STRUCTURE (2013)
Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses
Marisa K. Joubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
Yu Zhou et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Transferrin Antibodies into the Brain
Mark S. Dennis et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Transfer of engineered biophysical properties between different antibody formats and expression systems
Jonas V. Schaefer et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties
R. Castoldi et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
Paul A. Moore et al.
BLOOD (2011)
Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity
Jianying Dong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Targeted Therapy With the T-Cell-Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Max S. Topp et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting
Ingo Schubert et al.
MABS (2011)
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
Wolfgang Schaefer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting
Markus Kuegler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies
Leo Borras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Catumaxomab Clinical development and future directions
Rolf Linke et al.
MABS (2010)
Chemical generation of bispecific antibodies
Venkata R. Doppalapudi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
Ralf Lutterbuese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Remodeling domain interfaces to enhance heterodimer formation
Zhenping Zhu et al.
PROTEIN SCIENCE (2010)
Affinity and Avidity in Antibody-Based Tumor Targeting
Stephen I. Rudnick et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle et al.
CANCER RESEARCH (2009)
The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains
Annemarie Honegger et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
Chengbin Wu et al.
NATURE BIOTECHNOLOGY (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells
Daniel J. Lightwood et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Domain interactions in the Fab fragment:: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability
D Röthlisberger et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Stability improvement of antibodies for extracellular and intracellular applications:: CDR grafting to stable frameworks and structure-based framework engineering
S Ewert et al.
METHODS (2004)
Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis
A Wunder et al.
JOURNAL OF IMMUNOLOGY (2003)
Biophysical properties of human antibody variable domains
S Ewert et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Albumin binding as a general strategy for improving the pharmacokinetics of proteins
MS Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Yet another numbering scheme for immunoglobulin variable domains:: An automatic modeling and analysis tool
A Honegger et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Fab chains as an efficient heterodimerization scaffold for the production of recombinant bispecific and trispecific antibody derivatives
R Schoonjans et al.
JOURNAL OF IMMUNOLOGY (2000)
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies
C Rader et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides
A Knappik et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
